Cargando…

The EMT spectrum and therapeutic opportunities

Carcinomas are phenotypically arrayed along an epithelial–mesenchymal transition (EMT) spectrum, a developmental program currently exploited to understand the acquisition of drug resistance through a re‐routing of growth factor signaling. This review collates the current approaches employed in devel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Voon, Dominic C., Huang, Ruby Y., Jackson, Rebecca A., Thiery, Jean P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496500/ https://www.ncbi.nlm.nih.gov/pubmed/28544151 http://dx.doi.org/10.1002/1878-0261.12082

Ejemplares similares

EMT‐ and MET‐related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities
por: Kahlert, Ulf D., et al.
Publicado: (2017)

New insights into the role of EMT in tumor immune escape
por: Terry, Stéphane, et al.
Publicado: (2017)

The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
por: Huang, Yuhe, et al.
Publicado: (2022)

Tumor Budding: The Name is EMT. Partial EMT.
por: Grigore, Alexandru Dan, et al.
Publicado: (2016)

An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)
por: Huang, R Y-J, et al.
Publicado: (2013)

Cancer drug resistance induced by EMT: novel therapeutic strategies
por: De Las Rivas, Javier, et al.
Publicado: (2021)

EMT-Induced Stemness and Tumorigenicity Are Fueled by the EGFR/Ras Pathway
por: Voon, Dominic Chih-Cheng, et al.
Publicado: (2013)

Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity
por: Wu, Chin-Jui, et al.
Publicado: (2019)

Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120)
por: Huang, Ruby Yun-Ju, et al.
Publicado: (2015)

DSM-5 and autism spectrum disorders (ASDs): an opportunity for identifying ASD subtypes
por: Grzadzinski, Rebecca, et al.
Publicado: (2013)

Can Natural Products Targeting EMT Serve as the Future Anticancer Therapeutics?
por: Anwar, Sirajudheen, et al.
Publicado: (2022)

Biomarkers for autism spectrum disorder: opportunities for magnetoencephalography (MEG)
por: Roberts, Timothy P. L., et al.
Publicado: (2021)

Stem cells: a window of opportunity in low-dimensional EMT space
por: Nie, Qing
Publicado: (2018)

Extended-Spectrum β-Lactamases (ESBL): Challenges and Opportunities
por: Husna, Asmaul, et al.
Publicado: (2023)

A new dimension in drug discovery: reversing epithelial–mesenchymal transition (EMT)
por: Yun-Ju Huang, Ruby, et al.
Publicado: (2016)

Heterogeneity and plasticity of epithelial–mesenchymal transition (EMT) in cancer metastasis: Focusing on partial EMT and regulatory mechanisms
por: Li, Dandan, et al.
Publicado: (2023)

Therapeutic opportunities for targeting microRNAs in cancer
por: Taylor, Molly A, et al.
Publicado: (2014)

Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
por: Tan, Tuan Zea, et al.
Publicado: (2014)

Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities
por: Rambow, Florian, et al.
Publicado: (2019)

EMT and tumor metastasis
por: Heerboth, Sarah, et al.
Publicado: (2015)

Challenges and Therapeutic Opportunities of Autophagy in Cancer Therapy
por: Silva, Valdenizia R., et al.
Publicado: (2020)

Exploring the pathophysiology of post-sepsis syndrome to identify therapeutic opportunities
por: van der Slikke, Elisabeth C., et al.
Publicado: (2020)

Rho GTPases in Intellectual Disability: From Genetics to Therapeutic Opportunities
por: Zamboni, Valentina, et al.
Publicado: (2018)

Sirtuins and Hypoxia in EMT Control
por: Aventaggiato, Michele, et al.
Publicado: (2022)

New Opportunities in Glycan Engineering for Therapeutic Proteins
por: Zhong, Xiaotian, et al.
Publicado: (2022)

Insights into the Role of Sialylation in Cancer Metastasis, Immunity, and Therapeutic Opportunity
por: Huang, Jianmei, et al.
Publicado: (2022)

Angiogenesis and Its Therapeutic Opportunities
por: Yoo, So Young, et al.
Publicado: (2013)

CDK8-Novel Therapeutic Opportunities
por: Menzl, Ingeborg, et al.
Publicado: (2019)

Aberrant Sialylation in Cancer: Therapeutic Opportunities
por: Munkley, Jennifer
Publicado: (2022)

Radiation-induced senescence: therapeutic opportunities
por: Kim, Jae Ho, et al.
Publicado: (2023)

Bilirubin as a Therapeutic Molecule: Challenges and Opportunities
por: Adin, Christopher A.
Publicado: (2021)

Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application
por: Yuan, Xun, et al.
Publicado: (2014)

Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention
por: Kaufhold, Samantha, et al.
Publicado: (2014)

Consequences of EMT-Driven Changes in the Immune Microenvironment of Breast Cancer and Therapeutic Response of Cancer Cells
por: Singh, Snahlata, et al.
Publicado: (2019)

Senescence and cancer — role and therapeutic opportunities
por: Schmitt, Clemens A., et al.
Publicado: (2022)

Interplay of EMT and CSC in Cancer and the Potential Therapeutic Strategies
por: Tanabe, Shihori, et al.
Publicado: (2020)

Emerging therapeutic opportunities for integrin inhibitors
por: Slack, R. J., et al.
Publicado: (2021)

Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
por: Hammond, Suzan M, et al.
Publicado: (2021)

Role of EMT in Metastasis and Therapy Resistance
por: Smith, Bethany N., et al.
Publicado: (2016)

Heat Shock Proteins and Ovarian Cancer: Important Roles and Therapeutic Opportunities
por: Hoter, Abdullah, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8afgt723vroobe9q1n8j1gvj0p